Literature DB >> 25684944

Occult infection related hepatitis B surface antigen variants showing lowered secretion capacity.

Hong Kim1, Seoung-Ae Lee1, You-Sub Won1, HyunJoo Lee1, Bum-Joon Kim1.   

Abstract

AIM: To elucidate the molecular mechanisms underlying hepatitis B virus (HBV) occult infection of genotype C.
METHODS: A total of 10 types of hepatitis B surface antigen (HBsAg) variants from a Korean occult cohort were used. After a complete HBV genome plasmid mutated such that it does not express HBsAg and plasmid encoding, each HBsAg variant was transiently co-transfected into HuH-7 cells. The secretion capacity and intracellular expression of the HBV virions and HBsAgs in their respective variants were analyzed using real-time quantitative polymerase chain reaction assays and commercial HBsAg enzyme-linked immunosorbent assays, respectively.
RESULTS: All variants exhibited lower levels of HBsAg secretion into the medium compared with the wild type. In particular, in eight of the ten variants, very low levels of HBsAg secretion that were similar to the negative control were detected. In contrast, most variants (9/10) exhibited normal virion secretion capacities comparable with, or even higher than, the wild type. This provided new insight into the intrinsic nature of occult HBV infection, which leads to HBsAg sero-negativeness but has horizontal infectivity. Furthermore, most variants generated higher reactive oxidative species production than the wild type. This finding provides potential links between occult HBV infection and liver disease progression.
CONCLUSION: The presently obtained data indicate that deficiency in the secretion capacity of HBsAg variants may have a pivotal function in the occult infections of HBV genotype C.

Entities:  

Keywords:  Genotype C; Hepatitis B surface antigen; Hepatitis B virus; Occult infection; Reactive oxidative species; Variants

Mesh:

Substances:

Year:  2015        PMID: 25684944      PMCID: PMC4323455          DOI: 10.3748/wjg.v21.i6.1794

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  33 in total

1.  A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group.

Authors:  E Orito; M Mizokami; H Sakugawa; K Michitaka; K Ishikawa; T Ichida; T Okanoue; H Yotsuyanagi; S Iino
Journal:  Hepatology       Date:  2001-01       Impact factor: 17.425

Review 2.  Lamivudine resistant occult HBV: implications for public health?

Authors:  Scott Bowden; Angeline Bartholomeusz; Stephen Locarnini
Journal:  J Hepatol       Date:  2003-04       Impact factor: 25.083

3.  Prevalence of naturally occurring surface antigen variants of hepatitis B virus in Korean patients infected chronically.

Authors:  Byung-Cheol Song; Sun-Hyun Kim; Hong Kim; Yuan-Hai Ying; Hyun-Ju Kim; Yoon-Jun Kim; Jung-Hwan Yoon; Hyo-Suk Lee; Chang-Yong Cha; Yoon-Hoh Kook; Bum-Joon Kim
Journal:  J Med Virol       Date:  2005-06       Impact factor: 2.327

4.  From hepatitis to hepatoma: lessons from type B viral hepatitis.

Authors:  D S Chen
Journal:  Science       Date:  1993-10-15       Impact factor: 47.728

5.  Genotypes and clinical phenotypes of hepatitis B virus in patients with chronic hepatitis B virus infection.

Authors:  Jia-Horng Kao; Pei-Jer Chen; Ming-Yang Lai; Ding-Shinn Chen
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

6.  Reduced secretion of virions and hepatitis B virus (HBV) surface antigen of a naturally occurring HBV variant correlates with the accumulation of the small S envelope protein in the endoplasmic reticulum and Golgi apparatus.

Authors:  Pong Kian Chua; Robert Yung-Liang Wang; Min-Hui Lin; Tetsuya Masuda; Fat-Moon Suk; Chiaho Shih
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 7.  Hepatitis B virus mutations related to liver disease progression of Korean patients.

Authors:  Bum-Joon Kim
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

8.  In vitro antiviral susceptibility of full-length clinical hepatitis B virus isolates cloned with a novel expression vector.

Authors:  Huiling Yang; Christopher Westland; Shelly Xiong; William E Delaney
Journal:  Antiviral Res       Date:  2004-01       Impact factor: 5.970

Review 9.  Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention.

Authors:  D Lavanchy
Journal:  J Clin Virol       Date:  2005-12       Impact factor: 3.168

Review 10.  Occult hepatitis B.

Authors:  Michael Torbenson; David L Thomas
Journal:  Lancet Infect Dis       Date:  2002-08       Impact factor: 25.071

View more
  17 in total

Review 1.  X region mutations of hepatitis B virus related to clinical severity.

Authors:  Hong Kim; Seoung-Ae Lee; Bum-Joon Kim
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

Review 2.  Precore/core region mutations of hepatitis B virus related to clinical severity.

Authors:  Hong Kim; Seoung-Ae Lee; Seung Yeon Do; Bum-Joon Kim
Journal:  World J Gastroenterol       Date:  2016-05-07       Impact factor: 5.742

3.  Induction of endoplasmic reticulum-derived oxidative stress by an occult infection related S surface antigen variant.

Authors:  In-Kyung Lee; Seoung-Ae Lee; Hong Kim; You-Sub Won; Bum-Joon Kim
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

4.  An Effective Antiviral Approach Targeting Hepatitis B Virus with NJK14047, a Novel and Selective Biphenyl Amide p38 Mitogen-Activated Protein Kinase Inhibitor.

Authors:  So-Young Kim; Hong Kim; Sang-Won Kim; Na-Rae Lee; Chae-Min Yi; Jinyuk Heo; Bum-Joon Kim; Nam-Jung Kim; Kyung-Soo Inn
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

Review 5.  Association of preS/S Mutations with Occult Hepatitis B Virus (HBV) Infection in South Korea: Transmission Potential of Distinct Occult HBV Variants.

Authors:  Hong Kim; Bum-Joon Kim
Journal:  Int J Mol Sci       Date:  2015-06-15       Impact factor: 5.923

Review 6.  Update on occult hepatitis B virus infection.

Authors:  Manoochehr Makvandi
Journal:  World J Gastroenterol       Date:  2016-10-21       Impact factor: 5.742

7.  Occult hepatitis B virus infection is not associated with disease progression of chronic hepatitis C virus infection.

Authors:  Junhyeon Cho; Sang Soo Lee; Yun Suk Choi; Yejoo Jeon; Jung Wha Chung; Joo Yeong Baeg; Won Keun Si; Eun Sun Jang; Jin-Wook Kim; Sook-Hyang Jeong
Journal:  World J Gastroenterol       Date:  2016-11-14       Impact factor: 5.742

8.  Molecular characterization of occult hepatitis B virus infection in patients with end-stage liver disease in Colombia.

Authors:  Julio Cesar Rendon; Fabian Cortes-Mancera; Juan Carlos Restrepo-Gutierrez; Sergio Hoyos; Maria-Cristina Navas
Journal:  PLoS One       Date:  2017-07-07       Impact factor: 3.240

9.  Characterization of Novel Hepatitis B Virus PreS/S-Gene Mutations in a Patient with Occult Hepatitis B Virus Infection.

Authors:  Jianhong Chen; Yan Liu; Jun Zhao; Zhihui Xu; Rongjuan Chen; Lanlan Si; Shanshan Lu; Xiaodong Li; Shuai Wang; Kai Zhang; Jin Li; Juqiang Han; Dongping Xu
Journal:  PLoS One       Date:  2016-05-16       Impact factor: 3.240

Review 10.  Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis.

Authors:  Alexander V Ivanov; Vladimir T Valuev-Elliston; Daria A Tyurina; Olga N Ivanova; Sergey N Kochetkov; Birke Bartosch; Maria G Isaguliants
Journal:  Oncotarget       Date:  2017-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.